Integra LifeSciences IART Private Label — Total Revenues

Other product segments

Similar metrics at other companies

COCOPrivate Label — Net Sales

$33.24M+28.1%

JBIProduct revenues — Total revenues

$188.8M+7.5%

SHCProduct — Total net revenues

$38.44M+25.7%

ESPRProduct sales, net — Total Revenues

$43.4M+24.3%

PGENProduct revenues, net — Total revenues

$21.83M+10,653%

BCRXProduct sales, net — Total revenues

$151.4M+5.3%

Questions, answered.

What is Integra LifeSciences's private label — total revenues?

Integra LifeSciences (IART) reported private label — total revenues of $29.14M in Q1 2026.

How has Integra LifeSciences's private label — total revenues changed year-over-year?

Integra LifeSciences's private label — total revenues increased by 7.1% year-over-year, from $27.21M to $29.14M.

What is the long-term trend for Integra LifeSciences's private label — total revenues?

Over 4 years (2021 to 2025), Integra LifeSciences's private label — total revenues has grown at a -2.8% compound annual growth rate (CAGR), from $124.75M to $111.25M.

What does private label — total revenues mean?

This metric represents the total net revenue generated from products manufactured by the company and sold under third-party brand names. It reflects the commercial performance and market demand for the company's contract manufacturing and private label business segment.